STYLAGE XXL Bi-Soft by Laboratoires Vivacy, France is a highly efficient hyaluronic acid-based dermal filler that enables the natural
correction of volume loss. Available wholesale.
NATURALLY RESTORE LOST VOLUME AND YOUTHFUL APPEARANCE
STYLAGE XXL Bi-Soft is an injectable dermal filler that utilizes a monophasic biocompatible hyaluronan serum paired with potent antioxidants to naturally boost the skin’s texture and appearance and restore the moisture lost through normal ageing or due to medical conditions.
This revolutionary filler utilizes Vivacy’s patented IPN-like technology that ensures better delivery of hyaluronic acid to visibly improve skin elasticity. This results in a more effective, longer-lasting method of resolving skin sagging, fine lines, and wrinkles that helps restore healthier, younger-looking skin.
Ingredients
Cross-linked IPN-Like Hyaluronic Acid + Mannitol
Concentration
- 21 mg/g Hyaluronic Acid
- 9 mg/mL Mannitol
What’s in the Box?
- 2 x 1mL pre-filled, sterile disposable syringe
- 2 x 27G½ needle
- 2 x 25G 40mm cannula
Duration of Effects
Stylage XXL effects can last up to 12-15 months. Depending on the patient’s skin type, daily activities, and method of application used, the duration of effects can vary.
Depth of Injection
The gel is intended for injection into the deep dermis or subcutaneous layer of the skin in the treated area.
Method of Use
This injectable dermal filler is used to address loss of facial volume resulting from natural ageing or various medical conditions. It is administered to the cheeks, temples, chin, and facial creases to minimize sagging and wrinkles.
This product should only be administered by a medical doctor or another licensed health professional.
Benefits
- Aids in natural volume build-up
- Corrects fine lines and moderate to deep wrinkles
- Can be used for chin remodeling
- Reduces signs of sagging
- Utilizes safe, biodegradable, and biocompatible materials paired with a patented production technology to minimize adverse reactions
Reviews
There are no reviews yet.